Patrice Matchaba, Novartis US Foundation president

Mer­ck, Sanofi join No­var­tis’ 10-year quest to im­prove clin­i­cal tri­al di­ver­si­ty as his­tor­i­cal­ly Black col­leges pitch in

Mer­ck and Sanofi are join­ing No­var­tis’ 10-year com­mit­ment to in­creas­ing di­ver­si­ty in clin­i­cal re­search through a col­lab­o­ra­tion with his­tor­i­cal­ly Black col­leges and uni­ver­si­ties.

With new grants worth $17.7 mil­lion, the so-called Bea­con of Hope pro­gram now to­tals more than $50 mil­lion in com­mit­ments over the decade-long project, which aims to ad­dress health dis­par­i­ties and en­hance di­ver­si­ty, eq­ui­ty and in­clu­sion across drug re­search and de­vel­op­ment, par­tic­u­lar­ly in clin­i­cal tri­als.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.